Individual Stock News:
1. Shenghong Technology's Hong Kong IPO prospectus has lapsed.
2. Luxshare Precision's Hong Kong IPO prospectus has lapsed.
3. BOSS Zhipin (02076.HK): The trustee will purchase approximately 410,600 Class A ordinary shares under the post-IPO share scheme.
4. Dingdang Health (09886.HK) expects adjusted net profit of no less than RMB 5 million for fiscal year 2025, turning a profit year-on-year.
5. Insil Intelligent (03696.HK) has been included in the Hang Seng Composite Index.
6. Hansoh Pharmaceutical (03692.HK): Ametinib mesylate tablets have been approved for marketing in the EU as a single drug treatment.
7. Yum China (09987.HK) spent approximately US$3 million to repurchase approximately 54,000 shares on February 18.
8. RoboSense (02498.HK) saw continued growth in LiDAR product sales in fiscal year 2025, achieving its first quarterly profit in Q4.
